These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30548592)

  • 1. Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study.
    Chularojanamontri L; Silpa-Archa N; Wongpraparut C; Limphoka P
    Int J Dermatol; 2019 May; 58(5):593-599. PubMed ID: 30548592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
    Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of acitretin for the treatment of psoriasis.
    Lee CS; Li K
    Expert Opin Drug Saf; 2009 Nov; 8(6):769-79. PubMed ID: 19998529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
    Dogra S; Jain A; Kanwar AJ
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acitretin].
    Dubertret L
    Ann Dermatol Venereol; 2011 Dec; 138(12):829-32. PubMed ID: 22137620
    [No Abstract]   [Full Text] [Related]  

  • 7. Acitretin revisited in the era of biologics.
    Booij MT; Van De Kerkhof PC
    J Dermatolog Treat; 2011 Apr; 22(2):86-9. PubMed ID: 20673152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-center retrospective study of long-term use of low-dose acitretin (Soriatane) for psoriasis.
    Lee E; Koo J
    J Dermatolog Treat; 2004 Jan; 15(1):8-13. PubMed ID: 14754643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review.
    Chen P; Li C; Xue R; Chen H; Tian X; Zeng K; Zhang X; Liang J
    J Dermatolog Treat; 2018 Jun; 29(4):353-363. PubMed ID: 29098909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
    Zhu T; Jin H; Shu D; Li F; Wu C
    Eur J Dermatol; 2018 Apr; 28(2):217-224. PubMed ID: 29619998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis.
    Muchenberger S; Schöpf E; Simon JC
    Br J Dermatol; 1997 Oct; 137(4):587-9. PubMed ID: 9390336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients.
    Chen W; Zhang X; Zhang W; Peng C; Zhu W; Chen X
    Sci Rep; 2018 Sep; 8(1):13182. PubMed ID: 30181619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.
    Pang ML; Murase JE; Koo J
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):953-64. PubMed ID: 18624682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrow band ultraviolet-B versus Goeckerman therapy for psoriasis with and without acitretin: A retrospective study.
    Çalıskan E; Tunca M; Açıkgöz G; Arca E; Yürekli A; Akar A
    Indian J Dermatol Venereol Leprol; 2015; 81(6):584-7. PubMed ID: 26515836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acitretin in combination with UVB or PUVA.
    Lebwohl M
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S22-4. PubMed ID: 10459143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acitretin.
    Ortiz NE; Nijhawan RI; Weinberg JM
    Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic arthritis risk in psoriasis patients prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide cohort study.
    Lin TL; Chang YL; Ho HJ; Chen YJ; Wu CY
    Rheumatology (Oxford); 2024 May; 63(6):1624-1631. PubMed ID: 37656926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing acitretin use in patients with plaque psoriasis.
    Chiricozzi A; Panduri S; Dini V; Tonini A; Gualtieri B; Romanelli M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.